13D/13G Filings - Barinthus Biotherapeutics plc. (BRNS)

Real time Form 13D and 13G transaction reports:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
  • Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Reported
DateTime
Transaction
Date
TypeCompany
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev ReportView
2025-02-11
6:43 pm
Purchase
2024-12-3113GBarinthus Biotherapeutics plc
BRNS
Frank W. Cawood3,384,513
8.400%
1,041,743increase
(+44.47%)
Filing
History
2024-11-01
11:20 am
Purchase
2024-11-0113GBarinthus Biotherapeutics plc
BRNS
M&G PLC5,197,349
13.190%
5,197,349increase
(New Position)
Filing
History
2024-10-15
11:07 am
Purchase
2024-10-0713GBarinthus Biotherapeutics plc
BRNS
Frank W. Cawood2,342,770
5.900%
2,342,770increase
(New Position)
Filing
History
2024-02-13
10:17 am
Unchanged
2024-02-1313GBarinthus Biotherapeutics plc
BRNS
M&G INVESTMENT MANAGEMENT LTD5,197,349
13.480%
0
(Unchanged)
Filing
History
2023-01-20
1:35 pm
Unchanged
2023-01-2013GBarinthus Biotherapeutics plc
BRNS
M&G INVESTMENT MANAGEMENT LTD5,197,349
13.940%
0
(Unchanged)
Filing
History
2022-10-07
4:36 pm
Purchase
2022-10-0713GBarinthus Biotherapeutics plc
BRNS
M&G INVESTMENT MANAGEMENT LTD5,197,349
13.970%
5,197,349increase
(New Position)
Filing
History
2022-02-11
10:00 am
Purchase
2021-12-3113GBarinthus Biotherapeutics plc
BRNS
Oxford Science Enterprises plc8,797,770
25.220%
8,797,770increase
(New Position)
Filing
History
2022-01-19
08:27 am
Unchanged
2022-01-1913GBarinthus Biotherapeutics plc
BRNS
M&G Alternatives Investment Management Ltd4,108,752
11.970%
0
(Unchanged)
Filing
History
2021-11-05
1:33 pm
Purchase
2021-04-2913GBarinthus Biotherapeutics plc
BRNS
M&G Alternatives Investment Management Ltd4,108,752
11.970%
4,108,752increase
(New Position)
Filing
History